Indirect bilirubin

2 papers1 finding

Human trial1
Animals1

Interventions

1

ID110521156

upin humans1

1 study

ID110521156 increases indirect bilirubin in humans.
“A reversible, dose-dependent increase in indirect bilirubin resolved within 2 days after the last dose”
Human trial28 days
ID110521156, a Novel Oral Small-Molecule GLP-1RA: Evidence of Favorable Safety Profile and Dose-Dependent Reduction in Body Weight and Glycemic Control after 28 Days of Treatment
ADA Scientific Sessions 2026 abstract5 Jun 2026

More on ID110521156

Latest

2 in 12 months

Chinese Journal of GerontologyYesterday

Effects of the hepatic mitochondrial ROS/TNF-α axis on bilirubin metabolism in aged rats and the regulatory mechanism of melatonin

Experiments in 10 ratsInterventions

ADA Scientific Sessions 2026 Abstract5 Jun

ID110521156, a Novel Oral Small-Molecule GLP-1RA: Evidence of Favorable Safety Profile and Dose-Dependent Reduction in Body Weight and Glycemic Control after 28 Days of Treatment

Randomised trial in peopleInterventions